Evolent Health, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Evolent Health, Inc. (EVH) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $11.49 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-02-25
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-12-31 was $5.11M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-09-30 was $1.21M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-06-30 was $1.56M, a 98.24% decline year-over-year.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-03-31 was $3.62M, a 3.65% decline year-over-year.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2025 was $11.49M, a 87.57% decline from fiscal 2024.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2024 was $92.51M, a 12.02% increase from fiscal 2023.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2023 was $82.58M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.32M derived: sum of 2 quarters · filed 2026-02-25 | $7.88M derived: sum of 3 quarters · filed 2026-02-25 | $11.49M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.76M derived: sum of 2 quarters · filed 2025-11-07 | $6.38M 10-Q · filed 2025-11-07 | $6.38M derived: sum of 4 quarters · filed 2026-02-25 |
| 2025-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $5.18M 10-Q · filed 2025-08-11 | $5.18M derived: sum of 3 quarters · filed 2026-02-25 | $5.18M derived: sum of 4 quarters · filed 2026-02-25 |
| 2025-03-31 | $3.62M 10-Q · filed 2025-05-09 | $3.62M derived: sum of 2 quarters · filed 2026-02-25 | $3.62M derived: sum of 3 quarters · filed 2026-02-25 | $92.37M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $88.75M derived: sum of 3 quarters · filed 2026-02-25 | $92.51M 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $88.75M derived: sum of 2 quarters · filed 2025-11-07 | $92.51M 10-Q · filed 2025-11-07 | $143.04M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $88.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $92.51M 10-Q · filed 2025-08-11 | $143.04M derived: sum of 3 quarters · filed 2025-08-11 | $143.04M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $3.75M 10-Q · filed 2025-05-09 | $54.29M derived: sum of 2 quarters · filed 2025-05-09 | $54.29M derived: sum of 3 quarters · filed 2025-05-09 | $56.38M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $50.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $50.54M derived: sum of 2 quarters · filed 2025-02-21 | $52.62M derived: sum of 3 quarters · filed 2025-02-21 | $82.58M 10-K · filed 2025-02-21 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.09M derived: sum of 2 quarters · filed 2024-11-08 | $32.05M 10-Q · filed 2024-11-08 | $32.05M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $32.05M 10-Q · filed 2024-08-09 | $32.05M derived: sum of 3 quarters · filed 2024-08-09 | $32.05M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $29.96M 10-Q · filed 2024-05-10 | $29.96M derived: sum of 2 quarters · filed 2024-05-10 | $29.96M derived: sum of 3 quarters · filed 2024-05-10 | $29.96M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | $0.00 derived: sum of 3 quarters · filed 2024-02-23 | $0.00 10-K · filed 2024-02-23 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $0.00 derived: sum of 3 quarters · filed 2023-08-03 | $0.00 derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-05-04 | $0.00 derived: sum of 3 quarters · filed 2023-05-04 | $0.00 derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 derived: sum of 3 quarters · filed 2023-02-24 | $13.73M 10-K · filed 2023-02-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $13.73M 10-Q · filed 2022-11-03 | $13.73M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $13.73M 10-Q · filed 2022-08-03 | $13.73M derived: sum of 3 quarters · filed 2022-08-03 | $13.73M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $13.73M 10-Q · filed 2022-05-05 | $13.73M derived: sum of 2 quarters · filed 2022-05-05 | $13.73M derived: sum of 3 quarters · filed 2022-05-05 | $13.73M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $3.50M 10-K · filed 2022-02-24 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2021-08-05 | $3.50M 10-Q · filed 2021-11-04 | $3.50M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.50M 10-Q · filed 2021-08-05 | $3.50M derived: sum of 3 quarters · filed 2021-08-05 | $3.50M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $3.50M 10-Q · filed 2021-05-06 | $3.50M derived: sum of 2 quarters · filed 2021-05-06 | $3.50M derived: sum of 3 quarters · filed 2021-05-06 | $3.50M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | $800.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $800.00K 10-Q · filed 2020-11-06 | $800.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | $800.00K 10-Q · filed 2020-08-07 | $800.00K derived: sum of 3 quarters · filed 2020-05-28 | $800.00K derived: sum of 4 quarters · filed 2020-05-28 |
| 2019-03-31 | $800.00K 10-Q · filed 2020-05-28 | $800.00K derived: sum of 2 quarters · filed 2020-05-28 | $800.00K derived: sum of 3 quarters · filed 2020-05-28 | $800.00K derived: sum of 4 quarters · filed 2020-05-28 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |